Bonumose: Democratizing Healthy Sugar
You must be logged in to view presentation.
Sign In Register
Bonumose is developing a proprietary, cost-effective enzymatic process to bring these natural, low-glycemic sugars to market. The company takes starches left over from, for example, potato processing and, leveraging the natural power of enzymes, develops them into naturally-occurring ingredients in industrial-scale quantities. The webinar will also include a discussion of Bonumose’s patented process, one which permits the mass market application of tagatose and other nutritious sugars.
Learn more at: http://bonumose.com/
[Content protected for Tier 3, Management Company Professionals, Financial Professional, Selection Committee, Investor members only]
Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results. Securities are offered through North Capital Private Securities, member FINRA/SIPC. All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity.
